Patent Baristas

June 21, 2011 VOTE NO ON H.R. 1249 SPECIAL INTEREST PATENT BILL BENEFITS FOREIGN MULTINATIONAL CORPORATIONS OVER U.S. INVENTORS Dear Colleague: Please join us in opposing H.R. 1249.  While we may have different concerns with the legislation, as Members of Congress including two former Chairs of the House Judiciary Committee, a former Chair of the […]

The U.S. Supreme Court granted cert. (for the second time!) in Mayo Collaborative Services v. Prometheus Labs., Inc, Supreme Court No. 10-1150, to consider whether to set limits on when inventors can patent medical diagnostic tests. Earlier, the judgment was vacated and the case remanded to the U.S. Court of Appeals for the Federal Circuit […]

The one good feature of the “America Invents Act,” an end to fee diversion, is now removed.  Nothing remaining in the bill justifies the disruption and transition costs. Please ask your representative to vote no, and ask your clients to do the same. The bill is up for final vote on Wednesday (it has already […]

News out of Washington is that the Patent Reform Act is off again.  The main issue of debate appears to be the U.S. Patent and Trademark Office funding provisions in H.R. 1249, “The America Invents Act.” Section 22 of the Judiciary Committee reported bill allows the USPTO to retain all user fees to use for […]

Over 150 companies, associations, venture capitalists, unions, universities and innovation-focused entities  called on Congress to support keeping the U.S. Patent and Trademark Office funding provisions in H.R. 1249, “The America Invents Act.” Section 22 of the Judiciary Committee reported bill creates a mandatory revolving fund in the Treasury to retain all user fees collected by […]

It looks like the Patent Reform Act is no longer a done deal.  Tuesday afternoon, Rep. Harold Rogers (Chairman of the House Appropriations Committee) and Rep. Paul Ryan (Chairman of Budget) wrote a letter to Rep. Lamar Smith (Chairman of the Judiciary) insisting on maintaining the power of these two committees to control the Patent […]

Pharma IQ released the first in their series of Pharma IQ Top Blogger Awards. Their ten favorite regulatory and legal blogs are: Patent Docs:  A great legal blog covering patent issues in a great deal of depth. Eye on FDA:  Mark Senak charts every significant move of the FDA and other interesting regulatory developments that […]

Yesterday, the United States Supreme Court issued its opinion in the appeal of Stanford University against Roche Diagnostics. This case is of significant interest to the Biotechnology Industry Organization (BIO), Association of American Universities (AAU), American Council on Education (ACE), Association of Public and Land-grant Universities (APLU), Association of University Technology Managers (AUTM), and Council […]